Vasopressin increases both the urea permeability and osmotic water permeability in the terminal part of the renal inner medullary collecting duct (terminal IMCD). To identify the second messengers that mediate these responses, we measured urea permeability, osmotic water permeability, intracellular calcium concentration, and cyclic AMP accumulation in isolated terminal IMCDs. After addition of vasopressin, a transient rise in intracellular calcium occurred that was coincident with increases in cyclic AMP accumulation and urea permeability. Half-maximal increases in urea permeability and osmotic water permeability occurred with 0.01 nM vasopressin. The threshold concentration for a measurable increase in cyclic AMP accumulation was -0.01 nM, while measurable increases in intracellular calcium required much higher vasopressin concentrations (> 0.1 nM). Exogenous cyclic AMP (1 mM 8-Br-cAMP) mimicked the effect of vasopressin on urea permeability but did not produce a measurable change in intracellular calcium concentration. Conclusions: (a) Cyclic AMP is the second messenger that mediates the urea permeability response to vasopressin in the rat terminal IMCD. (b) Vasopressin increases the intracellular calcium concentration in the rat terminal IMCD, but the physiological role of this response is not yet known.
Introduction
Vasopressin increases both the urea permeability and the osmotic water permeability in the terminal part of the rat inner medullary collecting duct (terminal IMCD)' (1) (2) (3) . A urea permeability response to vasopressin does not occur in earlier portions of the collecting duct system including the cortical collecting duct (4) and initial part of the inner medullary collecting duct (3) . Thus, the action of vasopressin to increase urea permeability appears to be uniquely associated with the terminal IMCD. Urea reabsorption from the terminal collecting duct supplies most of the urea that accumulates in the inner medulla (5, 6) . Consequently, urea transport across the pressin are important components of the urinary concentrating mechanism.
It is generally accepted that the water permeability response in collecting ducts results from occupation of specific vasopressin receptors coupled to the activation of adenylate cyclase and generation of cyclic adenosine monophosphate (cyclic AMP) in the cells. In contrast, the second messenger or second messengers involved in the urea permeability response of the terminal collecting duct have not been determined. It is reasonable to propose, based on prior studies of vasopressinmediated stimulation of water permeability, that cyclic AMP mediates the vasopressin-induced increase in urea permeability in the terminal collecting duct. However, recent studies have demonstrated that another second messenger system, the phosphoinositide-calcium pathway, mediates vasopressin effects in several cell types including hepatocytes (7, 8) , vascular smooth muscle cells (9) , and renal glomerular mesangial cells (10) . In this pathway, as discussed in detail in several recent reviews (8, (10) (11) (12) (13) , calcium acts as an intracellular messenger in concert with two organic second messengers, inositol trisphosphate and diacylglycerol.
The chief objective of the present investigation was to determine whether either cyclic AMP or intracellular calcium act as second messengers in the vasopressin-dependent stimulation of urea permeability in the terminal IMCD. Toward this end, we have carried out measurements of urea permeability, osmotic water permeability, intracellular calcium concentration, and cyclic AMP accumulation in isolated terminal collecting ducts from rats.
Methods
Solutions. The compositions of solutions used are shown in Table I . Solutions containing bicarbonate were equilibrated continuously with 94% 02 and 6% CO2. Hepes-buffered solutions were gassed with 100% 02.
Chemicals were obtained from the following sources: synthetic atrial natriuretic factor (rat ANF Tubule microperfusion studies. IMCD from the kidneys of pathogen-free Sprague-Dawley rats (Small Animal Breeding Facility, National Institutes of Health) were isolated and perfused in vitro using previously-described procedures (6) . The tubule segments were dissected from the middle third of the inner medulla. When perfused, these tubules had a morphologic appearance consistent with that previously observed in the urea-permeable part of the inner medullary collecting duct (terminal IMCD) (6) . The tubule dissections were carried out at 15C in solution 1, 3, or 5 (Table I) chosen to match the initial perfusate solution. The dissected tubules were mounted on concentric pipets for in vitro microperfusion at 370C using method of Burg (14) . The length and diameter of the perfused tubules were measured with an eyepiece micrometer.
Urea permeability measurements. The urea permeability of inner medullary collecting ducts was determined by measuring the flux of urea resulting from an imposed 5 mM bath-to-lumen urea gradient. Tubules were dissected in solution 1 (Table I) , perfused with solution 1, and peritubular bath contained solution 2. The urea concentrations in collected fluid, perfusate and bath solutions were measured fluorometrically using a continuous flow ultramicrofluorometer (6) . The method is linear within the range of sample sizes used in these experiments (0-100 pmol). In this range of sample sizes, the method can resolve differences in urea content of 4% or greater.
The urea permeability (Pu) was calculated as: Pu = (CoVo -CLVL)/ (irDAC), where C0 is the urea concentration in the perfusate, CL is the urea concentration in the collected fluid, V0 is the perfusion rate per unit tubule length, VL is the collection rate per unit tubule length, AC is the mean urea concentration difference along the tubule, and D is the diameter of the perfused tubule. The perfusate urea concentration was zero for all experiments, thus obviating any need to measure VO. The collection rate was determined by measuring the length oftime needed to fill a calibrated volumetric pipette. In all experiments, the collection rate was increased to a level high enough (usually > 50 nl * min-' * mm-') to avoid dissipation of > 50% of the imposed urea concentration gradient. For each experimental condition, a mean value for tubule flow rate, collected urea concentration, net flux, and permeability was calculated from the results oftwo or three collections.
In the absence of vasopressin, the urea permeability ofthe terminal IMCD falls to a stable level within 40-50 min after the temperature is raised to 370C and this level is maintained for up to 120 min in the absence of added hormones (3) . Consequently, in this study we chose to make all measurements of urea permeability between 45 and 170 min after warming the tubules. When tubules were exposed to two different concentrations of AVP or dDAVP, an additional equilibration period of 30-40 min was allowed before measurements at the second concentration.
In experiments in which the temporal response to AVP was measured, the bath exchange to the vasopressin-containing solution was 90% complete within 15 s. Bath solutions were preheated to 37°C to avoid changes in temperature or pH in the bath chamber during the exchange. Water permeability measurements. The osmotic water permeability of inner medullary collecting ducts was determined by measuring the rate of water absorption resulting from an imposed osmotic gradient (100 mM bath-to-lumen NaCl gradient). Tubules were dissected in solution 3 (Table I) , perfused with solution 3, and the peritubular bath contained solution 4 . The osmolalities of the perfusate and bath were measured by vapor pressure osmometry (Wescor, Logan, UT) before the start of each experiment.
Creatinine was used as a volume marker. Previous studies have demonstrated that creatinine is a valid volume marker in the rat IMCD (3, 6) . The creatinine concentrations in collected fluid, perfusate, and bath solutions were measured using a continuous flow colorimeter using the alkaline picrate method (15) . The method is linear in the range of sample sizes used in these experiments (0-150 pmol) and can resolve differences between samples of 3% or greater. The NaCl permeability of this segment is low and is not affected by vasopressin (3) . Consequently, dissipation of the transepithelial osmolality gradient by passive NaCl entry is negligible.
The perfusion rate V0 was calculated using the equation VO = VL(XLJXO) where VL is the collection rate, XL is the collected creatinine concentration and X0 is the perfusate creatinine concentration. The fluorescence emission spectra of intracellular INDO-1 were measured at 37°C in isolated perfused tubules with a specially designed epifluorescence microscope spectrofluorometer (18, 19) , permitting simultaneous tubule perfusion and fluorescence spectroscopy. Light from a mercury arc lamp (Nikon, Inc.) was passed through a 366-nm interference filter (Corion, Holliston, MA), was reflected by a custom dichroic mirror (transmission > 400 nm; Andover Corp., Andover, MA), and then was focused to a 100-150 Mm spot by a 63X objective (N.A. 1.25; Zeiss, Thornwood, NJ). The emitted light passed through the dichroic mirror, and was spread out onto the face of a silicon intensified vidicon camera by a monochromator (Instruments SA Inc., Metuchen, NJ). Since the excitation light was not detected by the camera, a barrier filter was not required. Emission spectra were obtained by averaging 5-10 readings over 0.5 to 1 s. Background autofluorescence of the tubule was < 5% of the INDO-1 fluorescence throughout the measured spectrum from 400 to 550 nm, precluding the need to subtract the autofluorescence spectrum from the spectrum of INDO-l. Furthermore, 1O-8 M AVP added to the bath solution did not change background autofluorescence. A continuous flow bath exchange system prevented dye that may have leaked out of the cell from contributing to the measured fluorescence.
The calcium dependent shift in the emission spectrum of INDO-1 was quantitated using an intensity ratio method (17) . The two wavelengths used for emission intensity measurements were 409 nm and 480 nm. These wavelengths were chosen to maximize the sensitivity of the measurements. These wavelengths were identified by subtracting the emission spectrum of INDO-I in the presence of calcium from the emission spectrum in the absence of calcium and identifying the mini- Solutions also contained (in mM) glucose (5.5) and MgSO4 (1.2). Solutions containing bicarbonate were bubbled with 6% C02/94% 02. Bicarbonate-free solutions were bubbled with 100% 02.
mum and maximum (20) . The [Ca2"] was calculated from the ratio (R)
of the intensities measured simultaneously at the two wavelengths using (17):
where Kd is the dissociation constant of INDO-l (250 nM [17] ), Rm.
and Rmin are the emission intensity ratios obtained in the presence and absence of calcium; the remaining two terms are the emission intensities of INDO-l at 480 nm in the absence (sn) and presence (sb2) of calcium.
Calibration to determine Rmin, Rmax, and sf'Jsb2 in the cells was done in isolated perfused inner medullary collecting ducts by altering extracellular calcium in the presence of the calcium ionophore ionomycin. (Calibration was done in the cells because preliminary experiments showed that the intracellular environment alters the spectral properties of INDO-1 as is true for other trapped intracellular probes.) Tubules were dissected in Ca-free EGTA solution (solution 8, Table I ). They were loaded with INDO-1, and perfused using solution 8 in both the peritubular bath and luminal perfusate. The bath solution contained 5-10 gM ionomycin. Emission spectra were collected every 10-20 min until the intensity ratio reached a stable value. The bath solution was exchanged to solution 5 containing calcium and 5-10 AM ionomycin. Emission spectra were taken frequently until the intensity ratio reached a stable value. Fig. 1 shows the emission spectra ofintracellular INDO-1 at low and high bath calcium concentrations. Rmin was 0.372, Rm.,, was 1.047, and 21/4b2 was 1.624.
The course of a typical experiment in which intracellular calcium was measured is as follows. After mounting the tubule on the perfusion pipets and warming it to 37°C, a continuous bath exchange was established at 7-10 cm3/min fed from a heated bath exchange reservoir mounted above the perfusion apparatus. After a 30-40 min equilibration period, the basal intracellular calcium concentration was determined as the mean of two or more measurements. Then, agent or vehicle was added to the bath exchange reservior with vigorous mixing. Because of the dead space between the bath exchange reservoir and the perfusion chamber, there is a 25-s lag between addition ofagent to bath exchange reservoir and complete exchange of the peritubular bath. (This method ofchanging the peritubular bathing solution is utilized to avoid motion of the tubule or changes in bath temperature which may influence the intracellular calcium measurement.) Timed measurements ofintracellular calcium were made for 10 min after each change of the peritubular bath solution. At (20) lo-8 131±10 263±14* 140±13 AVP (7) 10-'°116±16 131±21 134±20 dDAVP (7) l0-, perfused and bathed with a HEPES-buffered solution (solution 5; Table I ). Additional intracellular calcium measurements were made in tubules perfused using the same bicarbonate-buffered solutions as the urea permeability protocol (solutions I and 2, Table I) . Cyclic AMP accumulation studies. Cyclic AMP accumulation in microdissected nonperfused segments ofrat inner medullary collecting duct was determined as described previously (21). A brief summary of the experimental approach follows. Pathogen-free Sprague-Dawley rats (85-150 g body wt) were decapitated and the left kidney was perfused with 10 ml of an ice-cold solution (solution 6, Table I) containing 1 mg/ml collagenase. The middle third of the inner medulla was isolated, dissected into four strips, and incubated in solution 6 containing collagenase for 30 min at 370C. Segments of inner medullary collecting ducts were microdissected at 17'C in solution 7 containing 0.05% BSA. After measuring the tubule lengths with an ocular micrometer, tubule segments were transferred in 2 gl of dissection solution to 18,Ml of solution 7 containing 0.56 mM IBMX at 4VC. The microdissected IMCDs were then equilibrated for 10 min at 37°C in a shaking water bath. 20 Ml of prewarmed solution 7 containing AVP or vehicle and 0.5 mM IBMX was then added, and the incubation was continued at 37°C. The incubation time after addition of AVP or vehicle was 2 min in the dose-response experiments and was varied between 0 and 10 min in the time course experiments. The reaction was stopped by adding 50 gl of 10% TCA followed by immediate vortexing. After centrifugation, the supernatant was frozen at -20°C overnight. In each experiment, blank samples (containing medium and TCA without tubules) were processed.
The TCA was removed by extraction with 0.75 ml water-saturated ether. The aqueous phase was dried, then 100 ul of 50 mM sodium acetate buffer (pH 6.2) was added to each sample. The cAMP content was measured by radioimmunoassay (New England Nuclear, Boston, MA) as described previously (21). Appropriate cAMP standards were carried through the entire assay procedure for determination of standard curves. 50% ofthe tracer displacement occurred at 99.8±4.8 fmol (n = 2).
To measure the time course ofthe response to vasopressin, IMCDs with a total length of -1 mm were used for each determination of cAMP accumulation. For the dose-response experiments, the tubule lengths used for each determination were 1.5 mm (control and 10-2 M AVP), 1.0 mm (10-" M AVP), 0.5 mm (10-10 M AVP), and 0.25 mm (10-9 AVP and greater). Statistics. All results are reported as mean± I SE. Statistical significance was determined using t tests (paired and unpaired). P < 0.05 indicated statistical significance.
Results
Time-course ofresponse to A VP Urea permeability. Fig. 2 shows the time-course ofurea permeability changes in response to 10-M and Io-8 M of AVP. The responses were normalized to express the percent maximal change, facilitating comparisons among tubules. An increase in the urea permeability was detected within 2 min. By 5 min, the urea permeability increased to -60% of the full response. After the initial rapid rise in permeability which occurred within 5-10 min, there was a slower increase that was complete within 30 min after addition of AVP. The mean unstimulated urea permeability in these four tubules was 25±9 X lo-5 cm/s. The urea permeability rose to an average of 79±17 X I0-cm/s within 40 min of AVP addition in the four tubules.
cAMP accumulation. Fig. 3 shows the time course of cAMP accumulation in microdissected nonperfused segments of the rat IMCD after addition of AVP (5 X 10-10 M) and in tubules not exposed to AVP. 0.5 mM IBMX was present in both groups. In the presence of AVP, an increase in cAMP accumulation was detected at 1 min. cAMP accumulation increased steadily over 10 min in both control and AVP-stimulated tubules.
Intracellular calcium. Fig. 4 shows the time course, in one tubule, of intracellular calcium concentration following addition of vehicle, then 10-8 M AVP. The results from all tubules are shown in Table II . The mean intracellular calcium concentration did not change significantly when vehicle (either water or 160 mM NaCl) was added to the bath (Table II) . (Table III) , 10-8 M dDAVP, a selective V2 receptor agonist, significantly increased the urea permeability by about twofold.
Osmotic water permeability. 10-" M AVP increased the osmotic water permeability of the rat IMCD (Table IV) . This increase was 44% of the maximal response (defined as the response to 10-8 M AVP). 10-10 M had about the same effect as 10-8 M AVP in two tubules (data not shown). Based on these limited data, the dose-response relationship for osmotic water permeability appears to be similar to that for urea permeability (Fig. 5) .
cAMP accumulation. The dose-response relationship for cAMP accumulation, measured in microdissected nonperfused segments of rat IMCD, is shown in Fig. 6 . There was a significant increase in cAMP accumulation at 10-" M AVP. The concentration ofAVP that caused a halfmaximal increase in cAMP accumulation was about 5 X 10-10 M.
Intracellular calcium. Fig. 7 shows the time course of intracellular calcium concentration in response to 10-0 and 10-8 AVP. The results for all experiments are summarized in Table II . At 10-'°M, AVP did not significantly alter the intracellular calcium concentration, despite the fact that this concentration caused nearly maximal increases in urea permeability and osmotic water permeability.
Response to exogenous cAMP The cyclic AMP analogue 8-Br-cAMP (1 mM added to the peritubular bath) reversibly increased the urea permeability of rat inner medullary collecting ducts (Table III) . However, 1 mM 8-Br-cAMP did not significantly alter the apparent intracellular calcium concentration ( Fig. 8 ; Table II ).
Effect ofINDO-J on urea permeability response It might be argued that 10`0 M AVP normally increases intracellular calcium, but did not do so in these experiments because intracellular INDO-1 acted as a calcium buffer. If this were true and if calcium normally mediates the urea perme- (Table III) . Therefore, regardless of whether INDO-I substantially buffers intracellular calcium, this result adds further support to the view that vasopressin can increase the urea permeability in the absence of a rise in intracellular free calcium concentration.
Effect ofother hormones and analogues on intracellular calcium dDA VP. dDAVP M added to the peritubulat bath significantly increased the calcium concentration (Table II) . The peak intracellular calcium concentration was similar to that seen with 1o-8 M AVP. As shown in Figs. 9 and 10, the time course of the increase in intracellular calcium concentration in response to 10-8 M dDAVP is similar to that seen with 10-8 M AVP.
Atrial natriuretic jactor. Atrial natriuretic factor (rat ANF1 28, 5 X 10 or 10-' M added to the peritubular bath) did not have a significant effect on intracellular calcium concentration ( Fig. 9 ; Table II) was no significant effect of 1010 M AVP on int: (Table II) .
in the peritubular bath did not prevent the calcium concentration in response to 1o-8 Bradykinin. Bradykinin, 10-6 M adde bath, did not have a significant effect on in concentration ( Fig. 10 ; Table It) . Furtherm of the tubules to bradykinin in the peritu prevent the rise in intracellular calcium co sponse to 10-8 M dDAVP (Fig. 10) . studies have also demonstrated that vasopressin causes a transient rise in intracellular calcium concentration. However, vasopressin-mediated increases in urea permeability and osmotic water permeability are not dependent on a rise in intracellular calcium. The physiologic role of the vasopressin-stimulated increase in intracellular calcium has not yet been identified. We review the basis for these conclusions and the relationship of the present results to prior observations. Physiologic role of vasopressin in the IMCD. The IMCD consists of at least two morphologically and functionally distinct subsegments (3, 22) . The initial part (initial IMCD), found in the outer third ofthe inner medulla, contains two cell types (intercalated and principal cells) and resembles the collecting duct from the inner stripe of the outer medulla (23) . ,___________ |
The terminal IMCD, the focus of the present study, contains only one cell type, usually termed a principal cell. The principal cell in the terminal IMCD differs from the principal cell of ae vasopressin (AVP) the initial IMCD. It contains a specialized urea transport lated perfused rat pathway, probably a carrier, which mediates an extremely yen tubules, there rapid rate of passive urea transport across the terminal collectracellular calcium ing duct epithelium (3, 6) . In the initial IMCD and more proximal collecting duct segments, this urea transport pathway is either absent or present in much lower activity (3) . The urea transport pathway in the terminal IMCD is important for the rise in intracellular urinary concentrating mechanism because it supplies nearly M dDAVP (Fig. 9) .
all of the urea that accumulates in the inner medullary inter-J to the peritubular stitium (5, 6 (Table II) .
Vasopressin (Table II) . It has been demonstrated in previous studies (1, 3) that vasopressin also increases osmotic water permeability in the terminal IMCD. The present results confirm this conclusion (Table IV) . As in other parts of the collecting duct system, the water permeability response in the terminal IMCD is thought to be mediated by cyclic AMP. The dose-response relationship for stimulation of water permeability by vasopressin is consistent with this conclusion. That is, the concentration of vasopressin required to elicit a water permeability response is similar to that required to increase urea permeability and cyclic AMP accumulation.
Calcium as a putative second messengerfor vasopressin in the IMCD. This paper contains the first reported evidence that vasopressin increases the intracellular calcium concentration in the terminal IMCD. The increase was a transient phenome-1,5 2'0 2 non with peak intracellular calcium concentrations occurring 60-90 s after addition of vasopressin to the peritubular bath.
DAVP on intracellu-
The intracellular calcium concentration then fell to near based rat inner medullary line levels within 3-5 min after vasopressin addition (Fig. 4) . was no significant efThe time course is similar to vasopressin-mediated increases in intracellular calcium activity seen in hepatocytes (8) (7) . The present studies were not designed to resolve the receptor subtype linked to the demonstrated rise in intracellular calcium in the terminal IMCD. Nevertheless it is interesting that the V2 selective vasopressin analogue dDAVP appeared to be nearly equipotent with arginine vasopressin in stimulating a rise in intracellular calcium (Table II) . This raises the possibility that the receptor responsible for vasopressinmediated increases in intracellular calcium in the IMCD may differ from its counterpart in other tissues. One possibility is that the rise in intracellular calcium results from the binding of vasopressin to oxytocin receptors. Oxytocin receptors have not been demonstrated in the IMCD, but are present in cultured renal tubule epithelia (LLC-PKI) where they are linked to the 1S 20 25 phosphoinositide-calcium pathway (32) .
Although vasopressin increases intracellular calcium in the )-8 M dDAVP on inrat terminal IMCD, it appears unlikely that calcium is a sec-I perfused rat inner ond messenger involved in the vasopressin-dependent in-)ules, there was no sigcreases in urea and water permeability. Two pieces ofevidence ular calcium (Table II) . support this conclusion. First, a nearly maximal increase in urea permeability was observed in response to 10-' M vasopressin, a concentration that produced no measurable change in intracellular calcium concentration.2 The permeability response to 10-10 M vasopressin occurred regardless of whether or not the cells were loaded with INDO-1. Therefore, calcium buffering by INDO-1 (if present) did not prevent the permeability response. Second, a large increase in urea permeability was seen in response to 1 mM 8-Br-cAMP despite the absence of a measurable change in intracellular calcium activity. Thus, it appears that large increases in urea permeability can occur without a demonstrable change in intracellular calcium concentration.
Ifcalcium is not a second messenger for stimulation ofurea and water permeability by vasopressin, then what physiological role could a rise in intracellular calcium in response to vasopressin play? It could be argued that the concentration of vasopressin required to raise intracellular calcium is so high that under physiological conditions, circulating concentrations are unlikely to rise high enough to cause the response. Thus, calcium-mediated responses to vasopressin may be important only in pathological conditions, such as hemorrhage, in which circulating vasopressin levels reach very high values. However, we are reluctant to draw such a conclusion based on the data obtained in the present study. Our reluctance stems from the fact that the in vitro conditions for our studies were chosen on the basis of a need to assure viability of the epithelium (6) and are not representative of the environment normally experienced in the inner medulla during antidiuresis. It is possible that the dose-response relationship for mobilization of intracellular calcium by vasopressin is altered by factors such as osmolality, ionic strength, and urea concentration that may vary in the inner medulla. Thus, we consider it reasonable to assume that vasopressin-induced changes in intracellular calcium could play some (as yet undiscovered) physiological role in the regulation of IMCD function.
